Research
Hormonal
GLP-1RAs appear to be safe and effective in patients with inflammatory bowel disease (IBD).
Healthcare providers can consider GLP-1RAs as a treatment option for IBD patients.
StrongSupportsmedium confidence
GLP-1RAs appear to be safe and effective in patients with IBD.
Why this rating
Based on a meta-analysis of observational studies.
Source
Can GLP-1 agonists be used safely in inflammatory bowel disease? A meta-analysis
Noppachai Siranart et al. · Journal of Crohn s and Colitis · 2025
Meta-analysisCited 1×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →